在血管化复合性全移植中,基于细胞的新型免疫调节策略
Maria Siemionow1, Yalcin Kulahci2, Fatih Zor3
1Department of Orthopeadics, University of Illinois at Chicago, Chicago, Illinois.
Current opinion in organ transplantation
|October 6, 2023
概括
细胞疗法提供了一个有希望的策略,以诱导耐受性和改善在血管化复合性全移植 (VCA) 的生存率. 需要进一步的研究来开发针对VCA的基于细胞的新型免疫抑制方案.
科学领域:
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
- 移植科学 移植科学
背景情况:
- 血管化复合性全体移植 (VCA) 面临着由于急性排斥和长期免疫抑制的副作用的挑战.
- 开发新的协议来诱导耐受性对于扩大VCA的临床应用至关重要.
- 基于细胞的疗法提供了一种创新的方法来克服这些局限性.
结论:
- 细胞疗法在诱导VCA中的耐受性方面具有显著的前景,得到新兴研究的支持.
- 需要进一步的研究来优化和建立新的基于细胞的VCA免疫抑制方案.
- 推进基于细胞的策略是提高VCA结果和患者生活质量的关键.
相关概念视频
Cell-mediated Immune Responses
68.7K
Overview
68.7K
Tissue Transplantation
384
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
384


